Nonlinear association between proteinuria levels and the risk of cardiovascular disease events and all-cause mortality among chronic kidney disease patients

References

• GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2020;395(10225):1–11. doi: 10.1016/S0140-6736(20)30045-3.
   PubMed Web of Science ®Google Scholar
• Foreman KJ, Marquez N, Dolgert A, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories. Lancet. 2018;392(10159):2052–2090. doi: 10.1016/S0140-6736(18)31694-5.
   PubMed Web of Science ®Google Scholar
• Thomas B, Matsushita K, Abate KH, et al. Global cardiovascular and renal outcomes of reduced GFR. J Am Soc Nephrol. 2017;28(7):2167–2179. doi: 10.1681/ASN.2016050562.
   PubMed Web of Science ®Google Scholar
• Di Angelantonio E, Chowdhury R, Sarwar N, et al. Chronic kidney disease and risk of major cardiovascular disease and non-vascular mortality: prospective population based cohort study. BMJ. 2010;341(sep30 1):c4986–c4986. doi: 10.1136/bmj.c4986.
   PubMedGoogle Scholar
• Li J, Liu FH, Guo J, et al. Retrospective analysis of renal prognosis in elderly coronary artery disease patients complicated with renal insufficiency. Aging (Albany NY). 2021;13(19):22856–22866. doi: 10.18632/aging.203579.
   PubMedGoogle Scholar
• Matsushita K, Coresh J, Sang Y, et al. Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data. Lancet Diabetes Endocrinol. 2015;3(7):514–525. doi: 10.1016/S2213-8587(15)00040-6.
   PubMed Web of Science ®Google Scholar
• Provenzano M, Chiodini P, Minutolo R, et al. Reclassification of chronic kidney disease patients for end-stage renal disease risk by proteinuria indexed to estimated glomerular filtration rate: multicentre prospective study in nephrology clinics. Nephrol Dial Transplant. 2020;35(1):138–147.
   PubMed Web of Science ®Google Scholar
• Shlipak MG, Matsushita K, Ärnlöv J, et al. Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med. 2013;369(10):932–943. doi: 10.1056/NEJMoa1214234.
   PubMed Web of Science ®Google Scholar
• Mok Y, Ballew SH, Sang Y, et al. Albuminuria as a predictor of cardiovascular outcomes in patients with acute myocardial infarction. J Am Heart Assoc. 2019;8(8):e010546.
   PubMed Web of Science ®Google Scholar
• Nagata M, Ninomiya T, Kiyohara Y, et al. Prediction of cardiovascular disease mortality by proteinuria and reduced kidney function: pooled analysis of 39,000 individuals from 7 cohort studies in Japan. Am J Epidemiol. 2013;178(1):1–11. doi: 10.1093/aje/kws447.
   PubMed Web of Science ®Google Scholar
• Li LC, Lee YT, Lee YW, et al. Aortic arch calcification predicts the renal function progression in patients with stage 3 to 5 chronic kidney disease. Biomed Res Int. 2015;2015:131263.
   PubMed Web of Science ®Google Scholar
• Roos CJ, Delgado V, de Koning EJ, et al. Associations of atherosclerosis in the descending thoracic aorta on CTA with arterial stiffness and chronic kidney disease in asymptomatic patients with diabetes mellitus. Int J Cardiovasc Imaging. 2014;30(6):1151–1159. doi: 10.1007/s10554-014-0441-9.
   PubMed Web of Science ®Google Scholar
• Soichiro I, Shotaro N, Yumi N, et al. Data from: prognosis of chronic kidney disease with normal-range proteinuria: the CKD-ROUTE study. Dryad Dataset. 2018;13:e0190493.
   Google Scholar
• Iimori S, Naito S, Noda Y, et al. Prognosis of chronic kidney disease with normal-range proteinuria: the CKD-ROUTE study. PLoS One. 2018;13(1):e0190493. doi: 10.1371/journal.pone.0190493.
   PubMed Web of Science ®Google Scholar
• Iimori S, Noda Y, Okado T, et al. Baseline characteristics and prevalence of cardiovascular disease in newly visiting or referred chronic kidney disease patients to nephrology centers in Japan: a prospective cohort study. BMC Nephrol. 2013;14(1):152. doi: 10.1186/1471-2369-14-152.
   PubMedGoogle Scholar
• Iimori S, Naito S, Noda Y, et al. Anaemia management and mortality risk in newly visiting patients with chronic kidney disease in Japan: the CKD-ROUTE study. Nephrology (Carlton). 2015;20(9):601–608. doi: 10.1111/nep.12493.
   PubMed Web of Science ®Google Scholar
• Levin A, Stevens PE. Summary of KDIGO 2012 CKD guideline: behind the scenes, need for guidance, and a framework for moving forward. Kidney Int. 2014;85(1):49–61. doi: 10.1038/ki.2013.444.
   PubMed Web of Science ®Google Scholar
• Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53(6):982–992. doi: 10.1053/j.ajkd.2008.12.034.
   PubMed Web of Science ®Google Scholar
• Tamura K, Yutoh J, Matsushita K, et al. Hypertension with chronic kidney disease: anti-hypertensive therapy recommended for the management of hypertension with CKD in JSN-CKD GL 2013 and JSH2014. Nihon Rinsho. 2015;73(11):1876–1884.
   PubMedGoogle Scholar
• Erviti J, Alonso A, Oliva B, et al. Oral bisphosphonates are associated with increased risk of subtrochanteric and diaphyseal fractures in elderly women: a nested case-control study. BMJ Open. 2013;3(1):e002091. doi: 10.1136/bmjopen-2012-002091.
   PubMed Web of Science ®Google Scholar
• Ozeki T, Nagata M, Katsuno T, et al. Nephrotic syndrome with focal segmental glomerular lesions unclassified by columbia classification; pathology and clinical implication. PLoS One. 2021;16(1):e0244677. doi: 10.1371/journal.pone.0244677.
   PubMed Web of Science ®Google Scholar
• Sethi S, Zand L, Nasr SH, et al. Focal and segmental glomerulosclerosis: clinical and kidney biopsy correlations. Clin Kidney J. 2014;7(6):531–537. doi: 10.1093/ckj/sfu100.
   PubMedGoogle Scholar
• Couser WG, Remuzzi G, Mendis S, et al. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int. 2011;80(12):1258–1270. doi: 10.1038/ki.2011.368.
   PubMed Web of Science ®Google Scholar
• Nagai K, Asahi K, Iseki K, et al. Estimating the prevalence of definitive chronic kidney disease in the Japanese general population. Clin Exp Nephrol. 2021;25(8):885–892. doi: 10.1007/s10157-021-02049-0.
   PubMed Web of Science ®Google Scholar
• Japan nephrology society. Special issue: clinical practice guidebook for diagnosis and treatment of chronic kidney disease 2012. Nihon Jinzo Gakkai Shi. 2012;54(8):1034–191.
   PubMedGoogle Scholar
• Takeuchi M, Shinkawa K, Yanagita M, et al. Prevalence, recognition and management of chronic kidney disease in Japan: population-based estimate using a healthcare database with routine health checkup data. Clin Kidney J. 2021;14(10):2197–2202. doi: 10.1093/ckj/sfab016.
   PubMed Web of Science ®Google Scholar
• Nitta K, Masakane I, Hanafusa N, et al. Annual dialysis data report 2017, JSDT renal data registry. Ren Replace Ther. 2019;5(1):53. doi: 10.1186/s41100-019-0248-1.
   Google Scholar
• Weaver DJ, Mitsnefes M. Cardiovascular disease in children and adolescents with chronic kidney disease. Semin Nephrol. 2018;38(6):559–569. doi: 10.1016/j.semnephrol.2018.08.002.
   PubMed Web of Science ®Google Scholar
• de Jager DJ, Vervloet MG, Dekker FW. Noncardiovascular mortality in CKD: an epidemiological perspective. Nat Rev Nephrol. 2014;10(4):208–214. doi: 10.1038/nrneph.2014.8.
   PubMed Web of Science ®Google Scholar
• Matsushita K, van der Velde M, Astor BC, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375(9731):2073–2081. doi: 10.1016/S0140-6736(10)60674-5.
   PubMed Web of Science ®Google Scholar
• Lin CC, Chen TY, Li CI, et al. Renal markers and risks of all cause and cardiovascular mortality from the taichung community based cohort study. Sci Rep. 2021;11(1):14143. doi: 10.1038/s41598-021-93627-5.
   PubMed Web of Science ®Google Scholar
• Kim HY, Kweon SS, Lee YH, et al. Cystatin C-based estimated GFR and albuminuria are independently associated with all-cause and CVD mortality in korean population: the dong-gu study. Maturitas. 2021;143:178–183. doi: 10.1016/j.maturitas.2020.10.016.
   PubMed Web of Science ®Google Scholar
• Su WY, Wu PY, Huang JC, et al. Increased proteinuria is associated with increased aortic arch calcification, Cardio-Thoracic ratio, rapid renal progression and increased overall and cardiovascular mortality in chronic kidney disease. Int J Med Sci. 2020;17(8):1102–1111. doi: 10.7150/ijms.45470.
   PubMed Web of Science ®Google Scholar
• Kühn A, van der Giet M, Kuhlmann MK, et al. Kidney function as risk factor and predictor of cardiovascular outcomes and mortality among older adults. Am J Kidney Dis. 2021;77(3):386–396.e1. doi: 10.1053/j.ajkd.2020.09.015.
   PubMed Web of Science ®Google Scholar
• Wu J, Jia J, Li Z, et al. Association of estimated glomerular filtration rate and proteinuria with all-cause mortality in community-based population in China: a result from kailuan study. Sci Rep. 2018;8(1):2157. doi: 10.1038/s41598-018-20554-3.
   PubMedGoogle Scholar
• Fung CS, Wan EY, Chan AK, et al. Association of estimated glomerular filtration rate and urine albumin-to-creatinine ratio with incidence of cardiovascular diseases and mortality in chinese patients with type 2 diabetes mellitus - a population-based retrospective cohort study. BMC Nephrol. 2017;18(1):47. doi: 10.1186/s12882-017-0468-y.
   PubMedGoogle Scholar
• Keith DS, Nichols GA, Gullion CM, et al. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med. 2004;164(6):659–663. doi: 10.1001/archinte.164.6.659.
   PubMed Web of Science ®Google Scholar
• Hemmelgarn BR, Manns BJ, Lloyd A, et al. Relation between kidney function, proteinuria, and adverse outcomes. Jama. 2010;303(5):423–429. doi: 10.1001/jama.2010.39.
   PubMed Web of Science ®Google Scholar
• Yilmaz MI, Sonmez A, Saglam M, et al. ADMA levels correlate with proteinuria, secondary amyloidosis, and endothelial dysfunction. J Am Soc Nephrol. 2008;19(2):388–395. doi: 10.1681/ASN.2007040461.
   PubMed Web of Science ®Google Scholar
• de Chickera SN, Bota SE, Kuwornu JP, et al. Albuminuria, reduced kidney function, and the risk of ST - and non-ST-segment-elevation myocardial infarction. J Am Heart Assoc. 2018;7(20):e009995.
   PubMed Web of Science ®Google Scholar
• Yilmaz MI, Romano M, Basarali MK, et al. The effect of corrected inflammation, oxidative stress and endothelial dysfunction on fmd levels in patients with selected chronic diseases: a Quasi-Experimental study. Sci Rep. 2020;10(1):9018. doi: 10.1038/s41598-020-65528-6.
   PubMed Web of Science ®Google Scholar
• Pedrinelli R, Giampietro O, Carmassi F, et al. Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet. 1994;344(8914):14–18. doi: 10.1016/s0140-6736(94)91047-2.
   PubMed Web of Science ®Google Scholar
• Askin L, Tanriverdi O, Turkmen S. Clinical importance of high- sensitivity troponin T in patients without coronary artery disease. North Clin Istanb. 2020;7(3):305–310. doi: 10.14744/nci.2019.71135.
   PubMed Web of Science ®Google Scholar
• Swoboda PP, McDiarmid AK, Erhayiem B, et al. Diabetes mellitus, microalbuminuria, and subclinical cardiac disease: identification and monitoring of individuals at risk of heart failure. J Am Heart Assoc. 2017;6(0 ):e005539.
   PubMedGoogle Scholar
• Mackinnon B, Deighan CJ, Norrie J, et al. The link between circulating markers of endothelial function and proteinuria in patients with primary glomerulonephritis. Clin Nephrol. 2005;63(3):173–180. doi: 10.5414/cnp63173.
   PubMed Web of Science ®Google Scholar
• Bitzan M, Hammad RM, Bonnefoy A, et al. Acquired thrombotic thrombocytopenic purpura with isolated CFHR3/1 deletion-rapid remission following complement blockade. Pediatr Nephrol. 2018;33(8):1437–1442. doi: 10.1007/s00467-018-3957-8.
   PubMed Web of Science ®Google Scholar
• Rensma SP, Stehouwer CDA, Van Boxtel MPJ, et al. Associations of arterial stiffness with cognitive performance, and the role of microvascular dysfunction: the Maastricht study. Hypertension. 2020;75(6):1607–1614. doi: 10.1161/HYPERTENSIONAHA.119.14307.
   PubMed Web of Science ®Google Scholar
• Shye M, Hanna RM, Patel SS, et al. Worsening proteinuria and renal function after intravitreal vascular endothelial growth factor blockade for diabetic proliferative retinopathy. Clin Kidney J. 2020;13(6):969–980. doi: 10.1093/ckj/sfaa049.
   PubMed Web of Science ®Google Scholar
• Zhang W, Feng LJ, Teng F, et al. Incidence and risk of proteinuria associated with newly approved vascular endothelial growth factor receptor tyrosine kinase inhibitors in cancer patients: an up-to-date meta-analysis of randomized controlled trials. Expert Rev Clin Pharmacol. 2020;13(3):311–320. doi: 10.1080/17512433.2020.1734450.
   PubMed Web of Science ®Google Scholar
• Sinha SK, Shaheen M, Singh VR, et al. How clinically relevant is C-reactive protein for blacks with metabolic syndrome to predict microalbuminuria? Metab Syndr Relat Disord. 2021;19(1):39–47. doi: 10.1089/met.2019.0121.
   PubMed Web of Science ®Google Scholar
• Liu L, Gao B, Wang J, et al. Clinical significance of single and persistent elevation of serum high-sensitivity C-reactive protein levels for prediction of kidney outcomes in patients with impaired fasting glucose or diabetes mellitus. J Nephrol. 2021;34(4):1179–1188. doi: 10.1007/s40620-020-00848-4.
   PubMed Web of Science ®Google Scholar
• Stehouwer CD, Gall MA, Twisk JW, et al. Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death. Diabetes. 2002;51(4):1157–1165. doi: 10.2337/diabetes.51.4.1157.
   PubMed Web of Science ®Google Scholar
• Maas R, Mieth M, Titze SI, et al. Drugs linked to plasma homoarginine in chronic kidney disease patients-a cross-sectional analysis of the German chronic kidney disease cohort. Nephrol Dial Trans-Plant. 2020;35(7):1187–1195. doi: 10.1093/ndt/gfy342.
   PubMed Web of Science ®Google Scholar